Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II open-label study of BAT7111 in advanced solid tumors
CTR20251802Phase 2Active
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Aug 2025
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BAT7111 in Nonhematologic neoplasms, sponsored by Bio-Thera Solutions, Ltd.. Started Aug 2025; status: active.
02
Drugs
BAT7111
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20251802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251802.